_id
69148bebccc777a4e85d99df
Ticker
PETVW
Name
PetVivo Holdings Inc. Warrant
Exchange
NASDAQ
Address
5151 Edina Industrial Boulevard, Edina, MN, United States, 55439
Country
USA
Sector
Healthcare
Industry
Medical Devices
Currency
USD
Website
https://www.petvivo.com
Description
PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals in the United States. The company's lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. It also provides therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Edina, Minnesota.
Last Close
0.0219
Volume
2700
Current Price
0.0275
Change
25.570776255707766
Last Updated
2025-11-12T13:30:19.008Z
Image
data:image/webp;base64,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
Ipo Date
2021-08-11T00:00:00.000Z
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
297500
Cost Of Revenue
110774
Gross Profit
186726
Operating Expenses
2031043
Operating Income
-1844317
Interest Expense
121808
Pretax Income
-2311037
Net Income
-2311037
Eps
-0.09509348515129333
Dividends Per Share
-
Shares Outstanding
24302790
Income Tax Expense
-
EBITDA
-2055617
Total Other Income Expense Net
-
Cash
3303844
Short Term Investments
150000
Receivables
25948
Inventories
529342
Total Current Assets
4400859
Property Plant Equipment
589653
Total Assets
6890496
Payables
744392
Short Term Debt
1526663
Long Term Debt
3431
Total Liabilities
3159519
Equity
3730977
Depreciation
133612
Change In Working Capital
-165735
Cash From Operations
-1633755
Capital Expenditures
521204
Cash From Investing
-521204
Cash From Financing
4709910
Net Change In Cash
3076155
PE
-
PB
0.1791291463335207
ROE
-61.94187206192908
ROA
-33.539486852615546
FCF
-2154959
Fcf Percent
-7.243559663865546
Piotroski FScore
1
Health Score
30
Deep Value Investing Score
3.5
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
4
Growth Investing Score
3
Momentum Investing Score
5
Net Net Investing Score
0.5
Quality Investing Score
2
Value Investing Score
4.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
297500
Quarters > 0 > income Statement > cost Of Revenue
110774
Quarters > 0 > income Statement > gross Profit
186726
Quarters > 0 > income Statement > operating Expenses
2031043
Quarters > 0 > income Statement > operating Income
-1844317
Quarters > 0 > income Statement > interest Expense
121808
Quarters > 0 > income Statement > pretax Income
-2311037
Quarters > 0 > income Statement > net Income
-2311037
Quarters > 0 > income Statement > eps
-0.09509348515129333
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
24302790
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-2055617
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > balance Sheet > cash
3303844
Quarters > 0 > balance Sheet > short Term Investments
150000
Quarters > 0 > balance Sheet > receivables
25948
Quarters > 0 > balance Sheet > inventories
529342
Quarters > 0 > balance Sheet > total Current Assets
4400859
Quarters > 0 > balance Sheet > property Plant Equipment
589653
Quarters > 0 > balance Sheet > total Assets
6890496
Quarters > 0 > balance Sheet > payables
744392
Quarters > 0 > balance Sheet > short Term Debt
1526663
Quarters > 0 > balance Sheet > long Term Debt
3431
Quarters > 0 > balance Sheet > total Liabilities
3159519
Quarters > 0 > balance Sheet > equity
3730977
Quarters > 0 > cash Flow > net Income
-2311037
Quarters > 0 > cash Flow > depreciation
133612
Quarters > 0 > cash Flow > change In Working Capital
-165735
Quarters > 0 > cash Flow > cash From Operations
-1633755
Quarters > 0 > cash Flow > capital Expenditures
521204
Quarters > 0 > cash Flow > cash From Investing
-521204
Quarters > 0 > cash Flow > cash From Financing
4709910
Quarters > 0 > cash Flow > net Change In Cash
3076155
Quarters > 0 > ratios > PE
-0.09509348515129333
Quarters > 0 > ratios > PB
0.1791291463335207
Quarters > 0 > ratios > ROE
-61.94187206192908
Quarters > 0 > ratios > ROA
-33.539486852615546
Quarters > 0 > ratios > FCF
-2154959
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-7.243559663865546
Quarters > 0 > health Score
30
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
224750
Quarters > 1 > income Statement > cost Of Revenue
42024
Quarters > 1 > income Statement > gross Profit
182726
Quarters > 1 > income Statement > operating Expenses
2304591
Quarters > 1 > income Statement > operating Income
-2079841
Quarters > 1 > income Statement > interest Expense
329947
Quarters > 1 > income Statement > pretax Income
-2419572
Quarters > 1 > income Statement > net Income
-2419572
Quarters > 1 > income Statement > eps
-0.10005865218575644
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
24181537
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > balance Sheet > cash
227689
Quarters > 1 > balance Sheet > short Term Investments
150000
Quarters > 1 > balance Sheet > receivables
60573
Quarters > 1 > balance Sheet > inventories
323504
Quarters > 1 > balance Sheet > total Current Assets
5609567
Quarters > 1 > balance Sheet > property Plant Equipment
1728413
Quarters > 1 > balance Sheet > total Assets
9339195
Quarters > 1 > balance Sheet > payables
821081
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
5442
Quarters > 1 > balance Sheet > total Liabilities
5119947
Quarters > 1 > balance Sheet > equity
4219248
Quarters > 1 > cash Flow > net Income
-2419572
Quarters > 1 > cash Flow > depreciation
254599
Quarters > 1 > cash Flow > change In Working Capital
303852
Quarters > 1 > cash Flow > cash From Operations
-1229975
Quarters > 1 > cash Flow > capital Expenditures
521204
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
1949977
Quarters > 1 > cash Flow > net Change In Cash
198798
Quarters > 1 > ratios > PE
-0.10005865218575644
Quarters > 1 > ratios > PB
0.15760919185124933
Quarters > 1 > ratios > ROE
-57.34604839535387
Quarters > 1 > ratios > ROA
-25.907714744150862
Quarters > 1 > ratios > FCF
-1751179
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-7.791675194660734
Quarters > 1 > health Score
24
Quarters > 2 > quarter
2024-12-31
Quarters > 2 > income Statement > revenue
583313
Quarters > 2 > income Statement > cost Of Revenue
61497
Quarters > 2 > income Statement > gross Profit
521816
Quarters > 2 > income Statement > operating Expenses
2280221
Quarters > 2 > income Statement > operating Income
-1758405
Quarters > 2 > income Statement > interest Expense
24378
Quarters > 2 > income Statement > pretax Income
-1757038
Quarters > 2 > income Statement > net Income
-1757038
Quarters > 2 > income Statement > eps
-0.08515701678884924
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
20632921
Quarters > 2 > income Statement > income Tax Expense
-1757038
Quarters > 2 > income Statement > EBITDA
-1700586
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > balance Sheet > cash
28891
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
493121
Quarters > 2 > balance Sheet > inventories
353307
Quarters > 2 > balance Sheet > total Current Assets
1226829
Quarters > 2 > balance Sheet > property Plant Equipment
1825417
Quarters > 2 > balance Sheet > total Assets
3112340
Quarters > 2 > balance Sheet > payables
1028679
Quarters > 2 > balance Sheet > short Term Debt
1497579
Quarters > 2 > balance Sheet > long Term Debt
7423
Quarters > 2 > balance Sheet > total Liabilities
3807121
Quarters > 2 > balance Sheet > equity
-694781
Quarters > 2 > cash Flow > net Income
-1757038
Quarters > 2 > cash Flow > depreciation
32074
Quarters > 2 > cash Flow > change In Working Capital
100127
Quarters > 2 > cash Flow > cash From Operations
-961216
Quarters > 2 > cash Flow > capital Expenditures
23632
Quarters > 2 > cash Flow > cash From Investing
-23632
Quarters > 2 > cash Flow > cash From Financing
887500
Quarters > 2 > cash Flow > net Change In Cash
-97348
Quarters > 2 > ratios > PE
-0.08515701678884924
Quarters > 2 > ratios > PB
-0.8166678816778237
Quarters > 2 > ratios > ROE
252.89091094891774
Quarters > 2 > ratios > ROA
-56.453922129330344
Quarters > 2 > ratios > FCF
-984848
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-1.6883697088869956
Quarters > 2 > health Score
31
Quarters > 3 > quarter
2024-09-30
Quarters > 3 > income Statement > revenue
200720
Quarters > 3 > income Statement > cost Of Revenue
21162
Quarters > 3 > income Statement > gross Profit
179558
Quarters > 3 > income Statement > operating Expenses
2352598
Quarters > 3 > income Statement > operating Income
-2173040
Quarters > 3 > income Statement > interest Expense
2452
Quarters > 3 > income Statement > pretax Income
-2175493
Quarters > 3 > income Statement > net Income
-2175493
Quarters > 3 > income Statement > eps
-0.10823835600558135
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
20099095
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-2139998
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > balance Sheet > cash
126239
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
133680
Quarters > 3 > balance Sheet > inventories
372115
Quarters > 3 > balance Sheet > total Current Assets
1246384
Quarters > 3 > balance Sheet > property Plant Equipment
1878887
Quarters > 3 > balance Sheet > total Assets
3186744
Quarters > 3 > balance Sheet > payables
762103
Quarters > 3 > balance Sheet > short Term Debt
700289
Quarters > 3 > balance Sheet > long Term Debt
9372
Quarters > 3 > balance Sheet > total Liabilities
2777573
Quarters > 3 > balance Sheet > equity
409171
Quarters > 3 > cash Flow > net Income
-2175493
Quarters > 3 > cash Flow > depreciation
33043
Quarters > 3 > cash Flow > change In Working Capital
-79141
Quarters > 3 > cash Flow > cash From Operations
-1600293
Quarters > 3 > cash Flow > capital Expenditures
15178
Quarters > 3 > cash Flow > cash From Investing
-3420
Quarters > 3 > cash Flow > cash From Financing
1717538
Quarters > 3 > cash Flow > net Change In Cash
113825
Quarters > 3 > ratios > PE
-0.10823835600558135
Quarters > 3 > ratios > PB
1.3508413658348222
Quarters > 3 > ratios > ROE
-531.6830860447099
Quarters > 3 > ratios > ROA
-68.2669520990704
Quarters > 3 > ratios > FCF
-1615471
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-8.048380829015544
Quarters > 3 > health Score
17
Valuation > metrics > PE
-0.09509348515129333
Valuation > metrics > PB
0.1791291463335207
Valuation > final Score
70
Valuation > verdict
82.1% Undervalued
Profitability > metrics > ROE
-61.94187206192908
Profitability > metrics > ROA
-52.513316150324286
Profitability > metrics > Net Margin
-7.768191596638656
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.8468342206344344
Risk > metrics > Interest Coverage
-15.141181203205043
Risk > final Score
-13
Risk > verdict
High
Liquidity > metrics > Current Ratio
1.9378037960331211
Liquidity > metrics > Quick Ratio
1.70472181431097
Liquidity > final Score
98
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
50
Prev Valuations > 2
80
Prev Profitabilities > 0
0
Prev Profitabilities > 1
40
Prev Profitabilities > 2
0
Prev Risks > 0
5
Prev Risks > 1
-259
Prev Risks > 2
-3539
Prev Liquidities > 0
100
Prev Liquidities > 1
27
Prev Liquidities > 2
40
Updated At
2026-01-20T22:23:05.217Z
PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals in the United States. The company's lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. It also provides therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Edina, Minnesota.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/APetVivo.ai Breaks the Mold: Launches Video Explainer Because "Nobody Reads Tech Press Releases Anymore" GlobeNewswire
Read more →(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of PetVivo Holdings Inc. Warrant
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.